236 related articles for article (PubMed ID: 32565980)
21. The prognostic impact of CDX2 correlates with the underlying mismatch repair status and BRAF mutational status but not with distant metastasis in colorectal cancer.
Neumann J; Heinemann V; Engel J; Kirchner T; Stintzing S
Virchows Arch; 2018 Aug; 473(2):199-207. PubMed ID: 29675807
[TBL] [Abstract][Full Text] [Related]
22. Comparative study of single-center patients with thyroid metastases from colorectal cancer and previously reported cases in the literature.
Keranmu A; Zheng H; Wu Y; Zhao J; Xu X; Liu F; Cai S; Wang Y; Xu Y
World J Surg Oncol; 2017 Apr; 15(1):88. PubMed ID: 28427420
[TBL] [Abstract][Full Text] [Related]
23. Impact of KRAS, BRAF, PIK3CA, TP53 status and intraindividual mutation heterogeneity on outcome after liver resection for colorectal cancer metastases.
Løes IM; Immervoll H; Sorbye H; Angelsen JH; Horn A; Knappskog S; Lønning PE
Int J Cancer; 2016 Aug; 139(3):647-56. PubMed ID: 26991344
[TBL] [Abstract][Full Text] [Related]
24. Association between clinicopathological features and survival in patients with primary and paired metastatic colorectal cancer and
Pang XL; Li QX; Ma ZP; Shi Y; Ma YQ; Li XX; Cui WL; Zhang W
Onco Targets Ther; 2017; 10():2645-2654. PubMed ID: 28579802
[TBL] [Abstract][Full Text] [Related]
25. Clinicopathological features of CpG island methylator phenotype-positive colorectal cancer and its adverse prognosis in relation to KRAS/BRAF mutation.
Lee S; Cho NY; Choi M; Yoo EJ; Kim JH; Kang GH
Pathol Int; 2008 Feb; 58(2):104-13. PubMed ID: 18199160
[TBL] [Abstract][Full Text] [Related]
26. The impact of KRAS mutations on prognosis in surgically resected colorectal cancer patients with liver and lung metastases: a retrospective analysis.
Kim HS; Heo JS; Lee J; Lee JY; Lee MY; Lim SH; Lee WY; Kim SH; Park YA; Cho YB; Yun SH; Kim ST; Park JO; Lim HY; Choi YS; Kwon WI; Kim HC; Park YS
BMC Cancer; 2016 Feb; 16():120. PubMed ID: 26887348
[TBL] [Abstract][Full Text] [Related]
27. Relationships among
Wan XB; Wang AQ; Cao J; Dong ZC; Li N; Yang S; Sun MM; Li Z; Luo SX
World J Gastroenterol; 2019 Feb; 25(7):808-823. PubMed ID: 30809081
[TBL] [Abstract][Full Text] [Related]
28. Impact of somatic mutations on patterns of metastasis in colorectal cancer.
Lipsyc M; Yaeger R
J Gastrointest Oncol; 2015 Dec; 6(6):645-9. PubMed ID: 26697197
[TBL] [Abstract][Full Text] [Related]
29. Genetic differences between lung metastases and liver metastases from left-sided microsatellite stable colorectal cancer: next generation sequencing and clinical implications.
Wang Z; Zheng X; Wang X; Chen Y; Li Z; Yu J; Yang W; Mao B; Zhang H; Li J; Shen L
Ann Transl Med; 2021 Jun; 9(12):967. PubMed ID: 34277767
[TBL] [Abstract][Full Text] [Related]
30. Mitochondrial DNA alteration in primary and metastatic colorectal cancer: Different frequency and association with selected clinicopathological and molecular markers.
Kleist B; Meurer T; Poetsch M
Tumour Biol; 2017 Mar; 39(3):1010428317692246. PubMed ID: 28345467
[TBL] [Abstract][Full Text] [Related]
31. Angiogenesis in primary colorectal cancer and matched metastatic tissues: Biological and clinical implications for anti-angiogenic therapies.
Yin L; Li J; Ma D; Li D; Sun Y
Oncol Lett; 2020 May; 19(5):3558-3566. PubMed ID: 32269630
[TBL] [Abstract][Full Text] [Related]
32. Differential diagnosis of pulmonary enteric adenocarcinoma and metastatic colorectal carcinoma with the assistance of next-generation sequencing and immunohistochemistry.
Zhang J; Xiang C; Han Y; Teng H; Li X; Shao J; Zhu L; Han-Zhang H; Ye J; Yu K
J Cancer Res Clin Oncol; 2019 Jan; 145(1):269-279. PubMed ID: 30415301
[TBL] [Abstract][Full Text] [Related]
33. Metastatic Profile of Colorectal Cancer: Interplay Between Primary Tumor Location and KRAS Status.
Zihui Yong Z; Ching GTH; Ching MTC
J Surg Res; 2020 Feb; 246():325-334. PubMed ID: 30737098
[TBL] [Abstract][Full Text] [Related]
34. Next generation sequencing of lung adenocarcinoma subtypes with intestinal differentiation reveals distinct molecular signatures associated with histomorphology and therapeutic options.
Jurmeister P; Vollbrecht C; Behnke A; Frost N; Arnold A; Treue D; Rückert JC; Neudecker J; Schweizer L; Klauschen F; Horst D; Hummel M; Dietel M; von Laffert M
Lung Cancer; 2019 Dec; 138():43-51. PubMed ID: 31634654
[TBL] [Abstract][Full Text] [Related]
35. Mutation analysis of KRAS in primary colorectal cancer and matched metastases by means of highly sensitivity molecular assay.
Miglio U; Mezzapelle R; Paganotti A; Allegrini S; Veggiani C; Antona J; Gentilli S; Monga G; Alabiso O; Boldorini R
Pathol Res Pract; 2013 Apr; 209(4):233-6. PubMed ID: 23538047
[TBL] [Abstract][Full Text] [Related]
36. Clinicopathologic features of gastric cancer with synchronous and metachronous colorectal cancer in Korea: are microsatellite instability and p53 overexpression useful markers for predicting colorectal cancer in gastric cancer patients?
Kim HJ; Kim N; Choi YJ; Yoon H; Shin CM; Park YS; Lee HS; Ahn SH; Park do J; Kim HH; Son IT; Kang SB; Lee DH
Gastric Cancer; 2016 Jul; 19(3):798-807. PubMed ID: 26445944
[TBL] [Abstract][Full Text] [Related]
37. [Clinical features and prognostic factors of brain metastasis from colorectal cancer].
Sun Z; Sun Y; Tan L; He J; Li X; She C; Li W
Zhonghua Zhong Liu Za Zhi; 2016 Jan; 38(1):63-8. PubMed ID: 26796809
[TBL] [Abstract][Full Text] [Related]
38. The Prognostic Value of Cancer Stem Cell Markers (Notch1, ALDH1, and CD44) in Primary Colorectal Carcinoma.
Mohamed SY; Kaf RM; Ahmed MM; Elwan A; Ashour HR; Ibrahim A
J Gastrointest Cancer; 2019 Dec; 50(4):824-837. PubMed ID: 30136202
[TBL] [Abstract][Full Text] [Related]
39. Predictive and Prognostic Implications of Mutation Profiling and Microsatellite Instability Status in Patients with Metastatic Colorectal Carcinoma.
Liu J; Zeng W; Huang C; Wang J; Yang D; Ma D
Gastroenterol Res Pract; 2018; 2018():4585802. PubMed ID: 29643917
[TBL] [Abstract][Full Text] [Related]
40. Spatio-temporal tumor heterogeneity in metastatic CRC tumors: a mutational-based approach.
Del Carmen S; Sayagués JM; Bengoechea O; Anduaga MF; Alcazar JA; Gervas R; García J; Orfao A; Bellvis LM; Sarasquete ME; Del Mar Abad M
Oncotarget; 2018 Sep; 9(76):34279-34288. PubMed ID: 30344942
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
